Email Us Here

[PangyoTechnoValley] SK Bioscience's COVID-19 Vaccine Enters Clinical Trials

- Synthetic antigen vaccine "NBP2001," non-clinical trials confirm safety and robust immune response to SARS CoV-2 virus - IND approval based on excellent nonclinical trial results. Will quickly verify in vivo safety and efficacy